These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7678783)

  • 1. Lymphokine-activated killing by human intestinal lymphocytes.
    Ebert EC; Roberts AI
    Cell Immunol; 1993 Jan; 146(1):107-16. PubMed ID: 7678783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    Tilden AB; Itoh K; Balch CM
    J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytotoxic effector cells: definition and analysis of activity.
    Ortaldo JR
    Allergol Immunopathol (Madr); 1991; 19(4):145-56. PubMed ID: 1726345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
    Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do the CD45RO+CD8+ intestinal intraepithelial T lymphocytes have the characteristics of memory cells?
    Ebert EC
    Cell Immunol; 1993 Apr; 147(2):331-40. PubMed ID: 8453675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of lymphokine release and cytolytic activities by activating peripheral blood lymphocytes via CD2.
    Valentin H; Groux H; Gelin C; Chretien I; Bernard A
    J Immunol; 1990 Feb; 144(3):875-82. PubMed ID: 1967277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual phenotype of intestinal intraepithelial lymphocytes in the rat: predominance of T cell receptor alpha/beta+/CD2- cells and high expression of the RT6 alloantigen.
    Fangmann J; Schwinzer R; Wonigeit K
    Eur J Immunol; 1991 Mar; 21(3):753-60. PubMed ID: 1707007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
    Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH
    Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
    Lynch DH; Miller RE
    J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
    Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
    Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro expansion of tumor-specific, HLA-restricted human CD8+ cytolytic T lymphocytes.
    Nakashima M; Watanabe T; Koprowski H; Schuchter L; Steplewski Z
    Cell Immunol; 1994 Apr; 155(1):53-61. PubMed ID: 7513262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion molecules on MHC-nonrestricted lymphocytes: high density expression and role in oncolysis.
    Savary CA; Lotzová E
    Lymphokine Cytokine Res; 1992 Jun; 11(3):149-56. PubMed ID: 1391234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of lymphokine-activated killer activity in T cells. Possible regulatory circuits.
    Geller RL; Smyth MJ; Strobl SL; Bach FH; Ruscetti FW; Longo DL; Ochoa AC
    J Immunol; 1991 May; 146(10):3280-8. PubMed ID: 1673980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of lymphokine-activated killer activity in T-replete and T-cell-depleted human bone marrow by interleukin 4.
    Drobyski WR; LeFever AV; Truitt RL
    Exp Hematol; 1991 Oct; 19(9):950-7. PubMed ID: 1716592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and characterization of cytotoxic T lymphocyte precursors in the murine intestinal intraepithelial leukocyte population.
    Ernst PB; Clark DA; Rosenthal KL; Befus AD; Bienenstock J
    J Immunol; 1986 Mar; 136(6):2121-6. PubMed ID: 2936822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
    Hogan PG; Hapel AJ; Doe WF
    J Immunol; 1985 Sep; 135(3):1731-8. PubMed ID: 3926882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12 up-regulates perforin- and Fas-mediated lymphokine-activated killer activity by intestinal intraepithelial lymphocytes.
    Ebert EC
    Clin Exp Immunol; 2004 Nov; 138(2):259-65. PubMed ID: 15498035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria.
    Schieferdecker HL; Ullrich R; Hirseland H; Zeitz M
    J Immunol; 1992 Oct; 149(8):2816-22. PubMed ID: 1383328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.
    Ballas ZK; Rasmussen W
    J Immunol; 1990 Jan; 144(1):386-95. PubMed ID: 2104892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.